Alzheimerraren diagnostikoa zirrikiturik gabeko kondena da oraindik paziente gehienen iruditerian. Urteotan ugaritu egin dira, ordea, eritasunari aurre egiteko terapien inguruko albisteak, eta hori...

Ghent, Belgium and Tokyo, Japan, May 11, 2026 - H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

Background Neuropsychiatric symptoms (NPS) are increasingly recognized as core features of Alzheimer's disease (AD), often emerging preclinically. Adults w...

Background Neuropsychiatric symptoms (NPS) are increasingly recognized as core features of Alzheimer's disease (AD), often emerging preclinically. Adults w...

Servicios informativos de Euskal Telebista que ofrecen tanto información cercana y local como noticias de ámbito internacional.

Gaur egungo albisteak, hemengoak zein nazioartekoak, eskaintzen dizkigun euskarazko albistegia.

This cohort study investigates race and ethnicity differences in plasma concentrations for biomarkers of Alzheimer disease and assesses the association between these biomarkers and medical conditions ...